fbpx

A New Way of
Diabetes Management

GluCare.Health patients are getting results, Fast.

We follow a clinical outcome based approach
& transparently report clinical results.

Book Appointment

GluCare.Health has reduced many other risks closely associated with Diabetes
in as little as 90 days.

%

⇩ Inflammation

%

⇩ Cholestrol LDL

%

⇧ Cholestrol HDL

%

⇩ Uric Acid

%

⇩ Body Weight

%

⇩ Cardiovascular

Over 2.1% reduction in HbA1c in just 90 days.

GluCare.Health patients have vastly better outcomes (in just 90 days) across a range of cardiometabolic parameters. Meanwhile patients receiving usual or traditional care saw no improvement or worsening of their condition with time.

RESULTS

Glucare
90 DAYS

Usual Care
90 DAYS

Usual Care
365 DAYS

HbA1c ⇩

- 2.14%

0.05%

+ 0.20%

CVD Risk ⇩

- 39.03%

-

-

BMI ⇩

- 4.49%

-

-

Body Weight ⇩

- 4.49%

0

0

Waist Circumference ⇩

- 5.15%

-

-

Triglycerides ⇩

- 18.52%

2.50%

+ 10%

LDL ⇩

- 17.25%

- 2.75%

+ 11%

HDL ⇧

+ 5.19%

- 0.75%

- 3%

ATL ⇩

- 9.44%

- 0.50%

- 2%

Uric Acid ⇩

- 20.40%

- 1%

- 4%

hsCRP ⇩

- 6.19%

3.75%

+ 15%

GluCare 90-Day Outcomes where signicantly different from baseline (p<0.05) for HbA1c, CV Risk, BMI, Body Weight, Wast Circumference, Triglycerides, LDL, Uric Acid.  For full details: Caccelli et al, Diabetes Manag (2021) 11(9), 290-296, Usual Care DOI: 10.1107/s 13300-018-0373-9

GluCare.Health
reduces the need for prescription medication

% Percentage Reduction Over 12 Months

Starting Point

3 Months

6 Months

9 Months

12 Months

100% on Insulin Medication

\

↓ Down to 60% usage in 3 Months

\

↓ Down to 43% usage in 6 Months

\

↓ Down to 18% usage in 9 Months

\

↓ Down to 4% usage in 12 Months

\

100% on Metformin Medication

\

↓ Down to 51% usage in 3 Months

\

↓ Down to 26% usage in 6 Months

\

↓ Down to 14% usage in 9 - 12 Months

\

100% on DPP4 Medication

\

↓ Down to 23% usage in 3 Months

\

↓ Down to 8% usage in 6 Months

\

100% Reduction in 9 Months

\

100% on SGLT2 Medication

\

↓ Down to 54% usage in 3 Months

\

↓ Down to 18% usage in 6 Months

\

↓ Down to 12% usage in 9 Months

\

↓ Down to 12% usage in 6 Months

\

↓ Down to 6% usage in 12 Months

\

100% on Sulfonyerea Medication

\

↓ Down to 19% usage in 3 Months

\

100% Reduction in 9 Months

\

What a reduction of 1% in HbA1c means for other complications

Association of Glycaemia with microvascular complications of
Type 2 diabetes (UKPDS 35)
prospective observation
study.

⇩ End-Point Disease Related to Diabetes

⇩ Death Related to Diabetes

⇩ Heart Attack

⇩ Microvascular Complication